➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
McKesson
Moodys
Baxter

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

DEXONE 0.5 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Dexone 0.5 patents expire, and when can generic versions of Dexone 0.5 launch?

Dexone 0.5 is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in DEXONE 0.5 is dexamethasone. There are thirty-nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.

US ANDA Litigation and Generic Entry Outlook for Dexone 0.5

A generic version of DEXONE 0.5 was approved as dexamethasone by XSPIRE PHARMA on April 28th, 1983.

  Start Trial

Summary for DEXONE 0.5
Drug patent expirations by year for DEXONE 0.5
Recent Clinical Trials for DEXONE 0.5

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Southwest Oncology GroupPhase 2
Janssen PharmaceuticalsPhase 2
University of California, San FranciscoPhase 2

See all DEXONE 0.5 clinical trials

US Patents and Regulatory Information for DEXONE 0.5

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay DEXONE 0.5 dexamethasone TABLET;ORAL 084991-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
McKesson
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.